EU Outsources Key Tobacco Control Responsibilities to Third Parties

Feb.27.2023
EU Outsources Key Tobacco Control Responsibilities to Third Parties
The EU outsources tobacco control responsibilities to non-elected bodies, causing concerns over accountability and potential conflicts of interest.

The European Tobacco Harm Reduction Advocates (ETHRA) has stated that the EU has outsourced key responsibilities for tobacco control to unelected organizations. ETHRA coordinates the actions of consumer groups and advocacy organizations throughout Europe. The organization warns that this has raised concerns about accountability and potential conflicts of interest.


EU officials had issued a tender notice for the "Support Action for the Tobacco Control Sector Single Framework Contract" earlier. Recently, they announced that the process has been completed and three contractors have been appointed.


The Spanish research and consultancy firm, Open Evidence, ...


The European Network for Smoking Prevention (ENSP)


Crete University


ETHRA has released a publicly available report which states that as part of their contribution, they will lead an "international consortium". This consortium will include the UK's ICF consultancy company, Brussels-based Milieu legal and policy consultancy, and Vital Strategies funded by Michael Bloomberg.


According to the Consumer Association, the contract will last for four years and is worth 3 million euros (approximately 22.03 million yuan).


According to the statement from ETHRA, the contractor's job will include:


Gather scientific literature, research, or clinical evaluations related to one or more tobacco or nicotine themes.


2. Statistical, market, and measurement analyses related to one or more tobacco or nicotine themes.


Tobacco Control Policy Model,


Behavioral research and analysis of specific issues.


Support for comprehensive health warnings,


Support for tobacco and related product labelling and packaging.


7. Restrictions on ingredients and related content/emission standards.


Support technological investment in information system development.


Conduct a legal assessment for the tobacco control measures of the European Union, countries, and international organizations.


The European Tobacco Harm Reduction Advocates (ETHRA) stated that the introductory notes in the tender specifications of the European Health and Digital Executive Agency (HaDEA) provide the legislative background of the EU's tobacco control policies, with the goal of achieving a "smoke-free tobacco generation" by 2040.


To achieve this goal, the plan is to revise the Tobacco Products Directive, which includes measures such as "implementing plain packaging and banning flavors in a completely transparent manner, improving the evaluation of ingredients through existing EU institutions, expanding taxes to new tobacco products, and addressing tobacco advertising, promotion, and sponsorship on the internet and social media.


According to the author of the document, there are concerns about the regulatory framework of the European Union. Currently, there is no systematic approach to dealing with all new tobacco and emerging products, and there is also a lack of flexibility to address rapidly developing products.


Advocates for reducing the harm of tobacco in Europe say, "This appears to be a daunting task for contractors. More importantly, it signifies that the policy-making responsibilities of the European Commission are now being outsourced to third parties. Accountability issues arise as well: when EU member states receive proposals to amend existing legislation, how do they know which proposals come from responsible officials and what role external actors played in shaping EU legislation?


Another issue is the potential conflict of interest with the winning bidder group. Of course, when it comes to the tobacco industry, they have a responsibility to declare that they have no conflict of interest in the tobacco industry. However, their work may have potential conflicts with other industries, such as the pharmaceutical industry that we may not be aware of.


References:


Efforts to Lobby on Behalf of Tobacco Industry The European Union (EU) has been found to be subcontracting its efforts to control tobacco, potentially undermining efforts to combat smoking. Investigations have discovered that the EU is employing companies which have links to the tobacco industry, leading to allegations of lobbying on behalf of the sector. The subcontractors are tasked with implementing tobacco control policies to be carried out across EU member states. Critics have voiced concern that this conflict of interest could threaten progress in reducing rates of smoking across Europe.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Product | FOGER Introduces Switch Pro 30K Nixodine Pod in U.S. Retail, Bringing 6-MN Related Formulation to High-Capacity Pod Platform
Product | FOGER Introduces Switch Pro 30K Nixodine Pod in U.S. Retail, Bringing 6-MN Related Formulation to High-Capacity Pod Platform
FOGER has introduced the Switch Pro 30K Nixodine Pod in U.S. retail channels, bringing a 6-methylnicotine (6-MN)-related formulation into its reusable Switch Pro 30K pod ecosystem. The product retains the existing reusable dock and magnetic replacement pod architecture, featuring a 19ml prefilled pod, dual-mesh heating and Normal/Boost modes. The Nixodine version is labeled nicotine-free in terms of conventional nicotine but uses a 5% Nixodine-related formulation. The product has appeared in U.S. retail and wholesale channels, with some listings indicating Kentucky-only availability.
Aug.28
PMI Q2 Call: ZYN Growth, IQOS Pricing and a Diverging Global Tobacco Market
PMI Q2 Call: ZYN Growth, IQOS Pricing and a Diverging Global Tobacco Market
Philip Morris International’s second-quarter earnings call offered new detail on its smoke-free strategy. Management said it would increase U.S. investment behind nicotine pouch brand ZYN, keep IQOS focused on volume before stronger pricing, and use SENTIA, DELIA, LEVIA, VEEV and ZYN to manage tax and regulatory pressure across Japan and Europe. Analysts from Goldman Sachs, Morgan Stanley, UBS and other firms also pressed PMI on profitability, market share, cigarette resilience and the durability of its global transformation over coming quarters.
Jul.24
JTI Makes Third Bet on South Korea as Ploom AURA Enters a Market Dominated by lil and IQOS
JTI Makes Third Bet on South Korea as Ploom AURA Enters a Market Dominated by lil and IQOS
Japan Tobacco International is stepping up its heated tobacco push in South Korea with Ploom AURA. Since its official launch in April 2026, the device's limited First Edition and Glacier White version have sold out, while distribution has expanded across Seoul, Incheon, Gyeonggi Province and airport duty-free channels. The rollout marks JTI's third major attempt to build a stronger heated tobacco position in South Korea, following Ploom TECH in 2019 and Ploom X Advanced in 2024. At the group level, JT plans to invest about ¥800 billion, approximately $5 billion, in reduced-risk products from 2026 through 2028, with heated products and Ploom identified as its primary investment priority.
Aug.14
Former FDA Scientist Questions ZYN Review Over Pouch Material and Microplastic Risk
Former FDA Scientist Questions ZYN Review Over Pouch Material and Microplastic Risk
A former FDA toxicologist has questioned whether the agency fully assessed the material used in ZYN nicotine pouches before authorizing them for sale, raising concerns over possible microplastic exposure, according to STAT and The Examination.
Jul.16
PMI Expands Colorado Investment to $1.2 Billion to Boost ZYN Nicotine Pouch Production
PMI Expands Colorado Investment to $1.2 Billion to Boost ZYN Nicotine Pouch Production
Philip Morris International (PMI) is expanding its investment in its Golden, Colorado campus, bringing total investment to approximately $1.2 billion to support its smoke-free products business. The investment will strengthen PMI’s research, production and innovation capabilities in smoke-free products. As one of the world’s largest tobacco companies, PMI has continued advancing its “Smoke-Free Future” strategy through heated tobacco, oral nicotine and other reduced-risk product categories.
PMI
Jul.28
Exclusive Analysis | Smoore H1 Revenue Rises 19.9% Amid Growth Concentration, Profit Pressure and Slowing Momentum
Exclusive Analysis | Smoore H1 Revenue Rises 19.9% Amid Growth Concentration, Profit Pressure and Slowing Momentum
Smoore’s first-half 2026 revenue rose 19.9%, but the results revealed growing structural risks beneath the headline growth. Heat-not-burn contributed about 61% of incremental revenue and remains driven largely by one core customer, while traditional vaping markets diverged, own-brand growth slowed and China enterprise revenue declined further. Gross profit and adjusted profit lagged revenue growth, while second-quarter revenue growth slowed to about 1.9%, putting greater focus on the quality, concentration and sustainability of Smoore’s expansion.
Capital Markets
Aug.20